We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
-1.71%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$39.1B
AUM Growth
-$2.58B
(-6.2%)
Cap. Flow
-$777M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
48.1%
Holding
304
New
7
Increased
61
Reduced
122
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$148M |
| 3 |
Meta Platforms (Facebook)
META
|
+$51.9M |
| 4 |
Spotify
SPOT
|
+$39.2M |
| 5 |
AbbVie
ABBV
|
+$38.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$391M |
| 2 |
Apple
AAPL
|
+$135M |
| 3 |
Broadridge
BR
|
+$99.4M |
| 4 |
CoStar Group
CSGP
|
+$97.2M |
| 5 |
Zoetis
ZTS
|
+$48.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.98% |
| 2 | Financials | 18.32% |
| 3 | Consumer Staples | 10.72% |
| 4 | Energy | 9.97% |
| 5 | Communication Services | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Targa Resources
TRGP
$60.7B
| $1.91M | ﹤0.01% |
7,614
| – | – |
|
152
Regeneron Pharmaceuticals
REGN
$70.9B
| $1.9M | ﹤0.01% |
2,460
-15
| -0.6% | -$11.5K |
|
153
Travelers Companies
TRV
$78.5B
| $1.78M | ﹤0.01% |
6,098
-700
| -10% | -$205K |
|
154
Lowe's Companies
LOW
$117B
| $1.75M | ﹤0.01% |
7,409
| – | – |
|
155
Thermo Fisher Scientific
TMO
$198B
| $1.73M | ﹤0.01% |
3,527
+185
| +6% | +$100K |
|
156
Vanguard S&P 500 ETF
VOO
$974B
| $1.72M | ﹤0.01% |
2,878
| – | – |
|
157
Bank of America
BAC
$430B
| $1.69M | ﹤0.01% |
34,750
+635
| +2% | +$32.8K |
|
158
DraftKings
DKNG
$12.4B
| $1.63M | ﹤0.01% |
75,500
| – | – |
|
159
Crown Holdings
CCK
$13.1B
| $1.62M | ﹤0.01% |
16,200
| – | – |
|
160
Lam Research
LRCX
$392B
| $1.61M | ﹤0.01% |
7,553
+1,419
| +23% | +$317K |
|
161
Danaher
DHR
$144B
| $1.59M | ﹤0.01% |
8,384
+85
| +1% | +$18.1K |
|
162
Ralph Lauren
RL
$22.6B
| $1.58M | ﹤0.01% |
4,580
| – | – |
|
163
Kirby Corp
KEX
$7.71B
| $1.52M | ﹤0.01% |
11,455
-823
| -7% | -$104K |
|
164
Charter Communications
CHTR
$16.2B
| $1.51M | ﹤0.01% |
6,974
| – | – |
|
165
Masco
MAS
$15.9B
| $1.45M | ﹤0.01% |
24,000
-2,075
| -8% | -$140K |
|
166
Constellation Brands
STZ
$22.7B
| $1.36M | ﹤0.01% |
9,100
| – | – |
|
167
NRG Energy
NRG
$27.2B
| $1.34M | ﹤0.01% |
9,147
| – | – |
|
168
Fomento Económico Mexicano
FMX
$44B
| $1.32M | ﹤0.01% |
11,882
-851
| -7% | -$91.6K |
|
169
Corning
GLW
$133B
| $1.31M | ﹤0.01% |
9,613
| – | – |
|
170
iShares Dow Jones US ETF
IYY
$2.94B
| $1.27M | ﹤0.01% |
8,000
| – | – |
|
171
iShares Core S&P 500 ETF
IVV
$881B
| $1.25M | ﹤0.01% |
1,919
-1,180
| -38% | -$806K |
|
172
Idexx Laboratories
IDXX
$44.8B
| $1.24M | ﹤0.01% |
2,204
-200
| -8% | -$128K |
|
173
MPLX
MPLX
$57.9B
| $1.19M | ﹤0.01% |
20,814
| – | – |
|
174
Williams Companies
WMB
$89.7B
| $1.17M | ﹤0.01% |
16,085
| – | – |
|
175
Ameriprise Financial
AMP
$47.5B
| $1.14M | ﹤0.01% |
2,570
-141
| -5% | -$67.9K |
|
Similar funds
HF
Fayez Sarofim & Co's Q1 2026 Portfolio in Review
As of Q1 2026, Fayez Sarofim & Co held 304 positions worth $39.1B, down 6.2% from $41.7B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Fayez Sarofim & Co's Q1 2026 filing shows 7 new, 61 increased, 122 reduced and 10 closed positions. Its largest new stake was Versant Media Group: 15,524 shares worth $575K. The largest sale was AstraZeneca, an estimated $391M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q1 2026 buy was Versant Media Group: 15,524 shares worth $575K.
- Fayez Sarofim & Co added most to Blackstone in Q1 2026, an estimated $189M increase.
- Fayez Sarofim & Co's biggest Q1 2026 reduction was Apple, cutting an estimated $135M.
- Fayez Sarofim & Co fully exited AstraZeneca in Q1 2026, selling an estimated $391M.
- Fayez Sarofim & Co's ten largest holdings make up 48% of its $39.1B portfolio in Q1 2026.
- Fayez Sarofim & Co opened 7 new positions and closed 10 in Q1 2026.
- Fayez Sarofim & Co's portfolio value fell 6.2% quarter-over-quarter to $39.1B.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.